Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Colonic Polyps 2Breast Neoplasms 2Rectal Diseases 1Prostatic Neoplasms 1Pneumoperitoneum 1Pancreatic Neoplasms 1Pain, Postoperative 1Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Gastric Subepithelial Tumor 1Erectile Dysfunction 1Endometriosis 1Diverticulitis 1Crohn Disease 1Constipation 1Colorectal Neoplasms 1Colonic Diseases 1Colitis, Ulcerative 1Carcinoma, Renal Cell 1Bites and Stings 1Bile Duct Neoplasms 1Agnosia 1

Interventions

Trastuzumab 594Paclitaxel 561Cyclophosphamide 545Docetaxel 478Capecitabine 387Letrozole 350Fulvestrant 310Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 175Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Surgical Instruments × Clear all
NCT06294574 2025-09-22

Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction

University of Alabama at Birmingham

Phase NA Recruiting
150 enrolled
Breast

Breast Neoplasms

NCT05173415 2025-02-24

MALLORCA

Brust-Zentrum AG

Phase NA Completed
40 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡